dihydroergotamine has been researched along with Nausea in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.88) | 18.7374 |
| 1990's | 9 (52.94) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 4 (23.53) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Braillon, A | 1 |
| Goadsby, PJ; Robbins, NM | 1 |
| Chou, DE; Goadsby, PJ; Tso, AR | 1 |
| Goadsby, PJ; Ito, H; Robbins, NM; Scheinman, MM | 1 |
| Lake, AE; Saper, JR; Swidan, SZ | 1 |
| Dalessio, D; Mathew, N; Sadowsky, C; Sheftell, F; Silberstein, SD; Solomon, S; Turkewitz, LJ; Winner, P | 1 |
| Baskin, SM; Queiroz, LP; Rapoport, AM; Sheftell, FD; Siegel, SE; Weeks, RE | 1 |
| Gallagher, RM | 1 |
| Mathew, NT | 1 |
| Lipton, RB | 1 |
| Ford, KT; Ford, RG | 1 |
| Barton, CW; Carleton, SC; Chelly, JE; Chudnofsky, CR; Johnson, G; Morris, DL; Pietrzak, MP; Rhee, KJ; Rosenberg, J; Shesser, RF; Starkman, S; Van Valen, MK | 1 |
| Hopkins, MM; Schulman, EA; Silberstein, SD | 1 |
| Backonja, M; Beinlich, B; Dulli, D; Schutta, HS | 1 |
3 review(s) available for dihydroergotamine and Nausea
| Article | Year |
|---|---|
MT 300--POZEN: dihydroergotamine mesylate injection.
Topics: Dihydroergotamine; Humans; Migraine Disorders; Nausea; Randomized Controlled Trials as Topic; Serotonin Receptor Agonists | 2003 |
Dosing and administration of ergotamine tartrate and dihydroergotamine.
Topics: Analgesics, Non-Narcotic; Cluster Headache; Dihydroergotamine; Dosage Forms; Ergotamine; Humans; Migraine Disorders; Nausea; Suppositories; Tablets; Vomiting | 1997 |
Ergotamine tartrate and dihydroergotamine mesylate: safety profiles.
Topics: Administration, Intranasal; Analgesics, Non-Narcotic; Animals; Consumer Product Safety; Dihydroergotamine; Drug Monitoring; Ergotamine; Humans; Migraine Disorders; Nausea; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic | 1997 |
5 trial(s) available for dihydroergotamine and Nausea
| Article | Year |
|---|---|
MT 300. Dihydroergotamine mesylate injection - POZEN.
Topics: Dihydroergotamine; Humans; Injections; Migraine Disorders; Nausea; Time Factors | 2003 |
Efficacy, safety, and tolerability of dihydroergotamine nasal spray as monotherapy in the treatment of acute migraine. Dihydroergotamine Nasal Spray Multicenter Investigators.
Topics: Acute Disease; Adolescent; Adult; Dihydroergotamine; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Nausea; Time Factors | 1995 |
Concomitant administration of antiemetics is not necessary with intramuscular dihydroergotamine.
Topics: Acute Disease; Adolescent; Adult; Aged; Antiemetics; Child; Dihydroergotamine; Drug Therapy, Combination; Female; Humans; Incidence; Injections, Intramuscular; Male; Migraine Disorders; Nausea; Office Visits; Prospective Studies; Time Factors | 1994 |
Acute treatment of migraine with dihydroergotamine nasal spray. Dihydroergotamine Working Group.
Topics: Acute Disease; Administration, Intranasal; Adolescent; Adult; Aged; Dihydroergotamine; Double-Blind Method; Female; Hallucinations; Humans; Male; Middle Aged; Migraine Disorders; Nausea; Placebos; Self Administration | 1996 |
Double-blind, multicenter trial to compare the efficacy of intramuscular dihydroergotamine plus hydroxyzine versus intramuscular meperidine plus hydroxyzine for the emergency department treatment of acute migraine headache.
Topics: Acute Disease; Adolescent; Adult; Analgesics, Non-Narcotic; Analgesics, Opioid; Antiemetics; Dihydroergotamine; Double-Blind Method; Drug Combinations; Emergency Service, Hospital; Female; Follow-Up Studies; Humans; Hydroxyzine; Injections, Intramuscular; Male; Meperidine; Middle Aged; Migraine Disorders; Nausea; Pain Measurement; Prospective Studies; Time Factors | 1998 |
9 other study(ies) available for dihydroergotamine and Nausea
| Article | Year |
|---|---|
Letter re: Safety of domperidone in treating nausea associated with dihydroergotamine infusion and headache.
Topics: Dihydroergotamine; Domperidone; Headache; Humans; Nausea | 2017 |
Author response: Safety of domperidone in treating nausea associated with dihydroergotamine infusion and headache.
Topics: Dihydroergotamine; Domperidone; Headache; Humans; Nausea | 2017 |
Aprepitant for the management of nausea with inpatient IV dihydroergotamine.
Topics: Administration, Intravenous; Administration, Oral; Analgesics, Non-Narcotic; Antiemetics; Aprepitant; Dihydroergotamine; Humans; Inpatients; Migraine Disorders; Morpholines; Nausea; Prospective Studies; Retrospective Studies; Treatment Outcome | 2016 |
Safety of domperidone in treating nausea associated with dihydroergotamine infusion and headache.
Topics: Adolescent; Adult; Aged; Antiemetics; Dihydroergotamine; Domperidone; Female; Headache; Humans; Male; Middle Aged; Migraine Disorders; Nausea; Prospective Studies; Retrospective Studies; Young Adult | 2016 |
Efficacy of intravenous diphenhydramine versus intravenous DHE-45 in the treatment of severe migraine headache.
Topics: Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Antiemetics; Dihydroergotamine; Diphenhydramine; Drug Therapy, Combination; Female; Histamine H1 Antagonists; Humans; Injections, Intravenous; Male; Metoclopramide; Middle Aged; Migraine Disorders; Nausea | 2005 |
Early and transient side effects of repetitive intravenous dihydroergotamine.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Chronic Disease; Dihydroergotamine; Female; Headache; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Prospective Studies | 1996 |
Continuous intravenous dihydroergotamine in the treatment of intractable headache.
Topics: Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Dihydroergotamine; Drug Stability; Female; Headache; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Pain, Intractable | 1997 |
Repetitive intravenous DHE in the treatment of refractory headache.
Topics: Chronic Disease; Cluster Headache; Dihydroergotamine; Headache; Humans; Injections, Intravenous; Nausea; Retrospective Studies | 1990 |
Haloperidol and lorazepam for the treatment of nausea and vomiting associated with the treatment of intractable migraine headaches.
Topics: Adult; Dihydroergotamine; Female; Haloperidol; Humans; Lorazepam; Migraine Disorders; Nausea; Vomiting | 1989 |